<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03961425</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01</org_study_id>
    <nct_id>NCT03961425</nct_id>
  </id_info>
  <brief_title>CO2 Field Saturating Alternative Techniques Comparison</brief_title>
  <official_title>Cardia Carbonaid VS Standard Cannula VS NO CO2 Approach: Impact on Time to Complete Deairing and Clinical Neurological Events; a Randomized Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiochirurgia E.H.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiochirurgia E.H.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective Randomized study comparing three strategy of deairing (NO CO2 insufflation, CO2
      insufflation with non specific cannula, CO2 insufflation with commercial dedicated diffuser)
      as regarding Time to Complete Deairing measured from declamping via TEE Echo and Neurological
      Events at Wake Up
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The impact of air bubbles into the cerebral circulation after open heart surgery has been a
      topic of discussion since the introduction of the heart-lung machine, and flooding the
      surgical field with CO2, which is heavier than Azote and Oxygen but over ten times more
      soluble seems a promising technique to minimize the presence of air microemboli. However very
      few studies have been conducted to ascertain what is the most efficient way to administer
      this treatment, or even of this treatment really impacts deairing time and clinical
      neurological events.

      This study aims at comparing the use of CO2 (administered in two different ways: a simple
      cannula, which might be prone to emulsioning air and CO2 not reaching a complete CO2
      saturation and a specific commercial diffuser which states promises complete filed
      saturation) to the no-CO2 standard approach.

      The primary end point will be Time to Complete deairing as measured by intraoperative
      transesophageal echo while the secondary end point will be the incidence of clinical
      neurological events the day after the operation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Random allocation in 1:1:1 to either NO CO2, CO2 with non specific cannula, CO2 with dedicated diffuser</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Clinical Outcomes are assessed by ICU physicians and the intraoperative strategy is not disclosed</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Complete Deairing</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Number of seconds since Declamping until no more air bubbles are visible on TEE Echo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurological Events at Wake Up</measure>
    <time_frame>The day after operation</time_frame>
    <description>Either Convulsions, Transitory Ischemic Attack or Full Stroke</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Embolism Air Post-Procedural</condition>
  <arm_group>
    <arm_group_label>NO CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional De Airing maneuver</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 Cannula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 at 8 l/min since 2 minutes before aortic cross clamp delivered by non specific needle cannula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 Cardia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 at 8 l/min since 2 minutes before aortic cross clamp delivered by commercial diffuser Cardia</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>NO CO2</intervention_name>
    <description>Traditional mechanical Deairing</description>
    <arm_group_label>NO CO2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 Cannula</intervention_name>
    <description>NON specific, low cost delivery system</description>
    <arm_group_label>CO2 Cannula</arm_group_label>
    <other_name>NON specific, low cost delivery system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 Cardia</intervention_name>
    <description>Specific Commercial CO2 Diffuser</description>
    <arm_group_label>CO2 Cardia</arm_group_label>
    <other_name>Specific Commercial CO2 Diffuser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Isolated, Elective Aortic Valve Replacement or combined AVR and CABG

        -

        Exclusion Criteria:

          -  any other kind of operation

          -  Urgency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Weltert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>European Hospital HEart Surgeon - Unicamillus Professor of Biostatistics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luca Weltert, MD</last_name>
    <phone>+393478880617</phone>
    <email>lweltert@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruggero De Paulis, MD</last_name>
    <email>rdepaulis58@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiochirurgia European Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca P Weltert, MD</last_name>
      <phone>06659751</phone>
      <email>lweltert@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luca P Weltert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Nyman J, Svenarud P, van der Linden J. Carbon dioxide de-airing in minimal invasive cardiac surgery, a new effective device. J Cardiothorac Surg. 2019 Jan 17;14(1):12. doi: 10.1186/s13019-018-0824-4.</citation>
    <PMID>30654802</PMID>
  </reference>
  <reference>
    <citation>Listewnik M, Kotfis K, Ślozowski P, Mokrzycki K, Brykczyński M. The influence of carbon dioxide field flooding in mitral valve operations with cardiopulmonary bypass on S100ß level in blood plasma in the aging brain. Clin Interv Aging. 2018 Sep 25;13:1837-1845. doi: 10.2147/CIA.S177356. eCollection 2018.</citation>
    <PMID>30288036</PMID>
  </reference>
  <reference>
    <citation>Benedetto U, Caputo M, Guida G, Bucciarelli-Ducci C, Thai J, Bryan A, Angelini GD. Carbon Dioxide Insufflation During Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials. Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):301-310. doi: 10.1053/j.semtcvs.2017.05.002. Epub 2017 May 23. Review.</citation>
    <PMID>29195572</PMID>
  </reference>
  <reference>
    <citation>Ganguly G, Dixit V, Patrikar S, Venkatraman R, Gorthi SP, Tiwari N. Carbon dioxide insufflation and neurocognitive outcome of open heart surgery. Asian Cardiovasc Thorac Ann. 2015 Sep;23(7):774-80. doi: 10.1177/0218492315583562. Epub 2015 May 4.</citation>
    <PMID>25939908</PMID>
  </reference>
  <reference>
    <citation>Chatterjee S, Greenberg SB, Brown J, Murphy GS, Pearson PJ, Alexander JC. Simple technique to verify CO(2) diffusion with the CarbonAid™ device. Heart Surg Forum. 2012 Aug;15(4):E212-4. doi: 10.1532/HSF98.20121015.</citation>
    <PMID>22917826</PMID>
  </reference>
  <reference>
    <citation>Chaudhuri K, Storey E, Lee GA, Bailey M, Chan J, Rosenfeldt FL, Pick A, Negri J, Gooi J, Zimmet A, Esmore D, Merry C, Rowland M, Lin E, Marasco SF. Carbon dioxide insufflation in open-chamber cardiac surgery: a double-blind, randomized clinical trial of neurocognitive effects. J Thorac Cardiovasc Surg. 2012 Sep;144(3):646-653.e1. doi: 10.1016/j.jtcvs.2012.04.010. Epub 2012 May 12.</citation>
    <PMID>22578685</PMID>
  </reference>
  <reference>
    <citation>Al-Rashidi F, Landenhed M, Blomquist S, Höglund P, Karlsson PA, Pierre L, Koul B. Comparison of the effectiveness and safety of a new de-airing technique with a standardized carbon dioxide insufflation technique in open left heart surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2011 May;141(5):1128-33. doi: 10.1016/j.jtcvs.2010.07.013. Epub 2010 Sep 3.</citation>
    <PMID>20817209</PMID>
  </reference>
  <reference>
    <citation>Martens S, Neumann K, Sodemann C, Deschka H, Wimmer-Greinecker G, Moritz A. Carbon dioxide field flooding reduces neurologic impairment after open heart surgery. Ann Thorac Surg. 2008 Feb;85(2):543-7. doi: 10.1016/j.athoracsur.2007.08.047.</citation>
    <PMID>18222261</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 22, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiochirurgia E.H.</investigator_affiliation>
    <investigator_full_name>Luca Weltert</investigator_full_name>
    <investigator_title>Professor of Biostatistics, Heart Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

